Publication | Closed Access

EUTOS score predicts survival and cytogenetic response in patients with chronic phase chronic myeloid leukemia treated with first-line imatinib

Hematological MalignancyHealth SciencesMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyMyeloid NeoplasiaEutos Score PredictsFirst-line ImatinibMolecular DiagnosticsRadiation OncologyOncologyCell BiologyAdult T-cell Leukemia-lymphomaCytogenetic Response